Arrhythmia: therapies Drugs for irregular heart rhythms, and anticoagulation Flashcards

(60 cards)

1
Q

What is an arrhythmia

A

Deviation from the normal rhythm of the heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Types of arrhythmias

A

Sinus
Tachycardia
Bradycardias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Tachycardias

A
Supraventricular (atrial fibillation and SVT (junctional)
Ventricular arrhythmia (Tachycardia and fibrillation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Resting Membrane Potential

A
  • During RMP the inside of the cell is a net negative charge relative to the outside
  • Dependent on the sodium-potassium ATPase pump (requires energy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Action Potential (3)

A
  1. Na+ enters the cell causing depolarisation once the threshold hits -40 mV
  2. Ca++ enters the cell, initiation of contraction
  3. K+ exits the cell causing repolarisation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Vaughan-Williams Classification antiarrhythmics

A

Class I- V

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Class IA electrophysiological property

A

(moderate) sodium-channel blockade, thus reducing amplitude of AP and conduction velocity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Class IA examples (3)

A

Quinidine
Procainamide
Dispyramide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Class IB electrophysiological property

A

(Weak) sodium-channel blockades, thus reducing amptitude of AP and conduction velocity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Class IB drugs examples (3)

A

Lidocaine
Mexeletine
Tocainide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Class IC electrophysiological properties

A

(strong) sodium-channel blockade thus reducing amplitude of AP and conduction velocity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Class IC drug examples

A

Flecainide

Propafenone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Class II electrophysiological properties

A

B-Adrenergic receptor antagonism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Class II examples

A

Atenolol

Bisoprolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Class III electrophysiological peoperties

A

Prolong refractoriness (slow K flow out of cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Class III drug examples

A

Amiodorane
Bretylium
Sotalol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Class IV electrophysiological properties

A

Calcium channel blockade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Class IV drug examples

A

Diltiazem

Verapamil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Class V drug

A

Other

Digoxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Class I drug most commonly used

A

Fleicanide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Action of Class II (2)

A

Prolongs phase 4 depolarisation (slows SA discharge and AV conduction and reduces excitability in non-nodal cardiac tissues)
Shortens phase 2- negative effect on contractility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

First line for atrial fibrillation

A

Class II drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Class III drugs are used for

A

dysrhythmias that are difficult to treat

• Life-threatening ventricular tachycardia or fibrillation, atrial fibrillation or flutter- resistant to other drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Use of Amiodarone

A

VT and supraventricular tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Drug interactions of Amidodarone
Digoxin
26
Side effects of Amiodarine (5)
``` Thyroid (hypo or hyper) Pulmonary fibrosis Slate grey pigmentation Corneal deposits LFT abnormalities ```
27
Class IV (4)
* Calcium channel blockers- bind to Lcard- type voltage gated Ca++ channels * Depress phase 4 depolarisation in SA and AV nodes * Slow the HR (decrease automaticity and slows AV conduction) * Shortens phase 2 plateau phase (reduce contractility)
28
Digoxin (class 5) properties
have properties of several classes and are not present in a particular class
29
Action of Digoxin (5)
* Cardiac glycoside * Inhibits the sodium-potassium ATPase pump * Increases vagal tone- slows SA/AV node conduction * Complex effect on the cardiac action potential- reduces the refractory period in the myocardium * Increases Ca++ intracellular- positive inotropic effect
30
Indications for Digoxin (2)
Atrial dysrhythmias | Heart failure
31
Digoxin Toxicity (6)
* Nausea and vomiting * Xanthopia- objects appear yellow * Bradycardia * Tachycardia * Arrhythmias: VT and VF * Reverse tick appearance of ST segment in lateral leads
32
Digoxin Toxicity Treatment (3)
Stop digoxin Give Digibind More serious is potassium levels are low
33
Action of Adenosine
Slows/blocks conduction through AV node
34
Use of Adenosine
Used to convert paroxysmal supraventricular tachycardia to sinus rythm
35
Features of Adenosine (4)
Very short half life Only administered as fast IV push May cause asystole for a few seconds Minimal side effects
36
All antiarrhythmics can cause___
arrhythmias
37
Indications for anticoagulation
Atrial fibrillation- risk of stroke and pulmonary embolism Metallic heart valves DVT/PE
38
Thrombosis in AF is caused when what 3 things are compromised
Stasis Abnormal blood Abnormal vessels
39
Characteristics of the ideal anti-coagulant (6)
* Oral * No need for monitoring * No interaction with food or drugs * Given once or twice a day/fixed dose irrespective of body weight/age * As effective as warfarin * Safer than warfarin
40
Oral anticoagulants and their function (3)
* Warfarin- Vitamin K reductase antagonist- prevents the production if active clotting factors * Dabigatran- Direct Thrombin Inhibitor * Rivaroxaban, Apixaban, Edoxaban- Direct Xa inhibitors
41
Production of Clotting factors (5)
1. Vitamin K epoxide reductase 2. Reduced vitamin K 3. Vitamin K epoxide 4. Clotting factor precursors 5. Complete clotting factors (II, VII, IX and X)
42
INR
Prothrombin Time Time it takes for blood to clot International normalised ratio
43
Normal INR
1
44
Therapeutic INR is normally
2.5-4.0
45
Adverse effects of Warfarin (6)
``` • Bleeding (dose related) • Interaction with multiple drugs • Pregnancy  Teratogenic (chondrodysplasia)  Retroplacental bleeding and foetal intracerebral bleeding  Avoid in first and third trimester ```
46
What enzyme metabolises Warfarin and what are the consequences of this (4)
Cytochrome P450 Interacts with drugs such as macrolide AB Antifungals Antiepileptic drugs
47
Drugs that increase warfarin activity (5)
``` Aspirin Sulfonamides Cimetidine Erythromycin Antibiotics (oral) ```
48
How does Aspirin | Sulfonamides increase warfarin activity
Decrease binding of warfarin to albumin
49
How does Cimetidine | Erythromycin increase warfarin activity
Inhibit degradation of warfarin
50
How does Antibiotics (oral) increase warfarin activity
Decrease synthesis of clotting factors
51
Drugs that promote bleeding (2)
Aspirin | Heparin
52
How does aspirin promote bleeding
Inhibition of platelets
53
How does Heparin promote bleeding
Inhibition of clotting factors
54
Drugs that decrease Warfarin activity (4)
Barbiturates Phenytoin Vitamin K Cholestyramine
55
How does Barbiturates and Phenytoin decrease warfarin activyt
Induction od metabolising enzyme cytochrome P450
56
How does Vitamin K decrease warfarin activity
Promote clotting factor synthesis
57
How does Cholestyramine decrease warfarin activity
Reduces absorption
58
Inhibitors of Cytochrome P450 (8) (increases effect of warfarin)
* Omeprazole * Disulfiram * Erythromycin * Valproate * Isoniazid * Ciprofloxacin and Cimetidine * Ethanol (acutely) * Sulphonamides
59
Inducers of Cytochrome P450 (reduced effect of Warfarin)
* Alcohol (chronic use) * Barbiturates * Carbamazepine * Phenytoin * Rifampicin * Sulphonylureas
60
Monitoring warfarin therapy (4)
* Regular INR * Watch if therapy altered * Patient education * Alcohol intake